ESR1 rs17231520: Reproductive Trait Genetics Explained
The single nucleotide polymorphism rs17231520 is a common germline genetic variant located in the estrogen receptor 1 (ESR1) gene locus on chromosome 6. Genetic studies have linked variation at this genomic site to subtle differences in reproductive endocrine regulation and markers of reproductive potential. Carrying one or more copies of the alternate allele represents a common background trait rather than a direct cause of disease.
What each genotype means
Typical endocrine profile
You carry two copies of the common C allele at rs17231520 in the ESR1 gene. Research associates this genotype with baseline estrogen receptor signaling and typical population ranges for reproductive endocrine markers. It is not linked with the subtle shifts in reproductive lifespan or hormone measures observed in minor allele carriers.
Carried by approximately 84% to 85% of individuals of European ancestry, and the vast majority of individuals globally.
Altered reproductive endocrine profile
You carry one copy of the T minor allele at rs17231520 in the ESR1 gene. Population association studies have linked the presence of this allele to modest variations in estrogen-dependent signaling and reproductive timing metrics. However, these effects are subtle, and reproductive health is shaped by many genetic and lifestyle factors.
Carried by roughly 14% to 15% of individuals of European ancestry, with lower prevalence in East Asian and African populations.
Modified reproductive endocrine profile
You carry two copies of the less common T allele at rs17231520 in the ESR1 gene. Studies observe the strongest statistical associations with modified estrogen receptor 1 activity and reproductive endocrine measures in individuals with two copies of this variant allele. Because published research demonstrates modest effect sizes and potential ancestry-specific variance, this finding represents a statistical association rather than a clinical condition.
Carried by less than 1% of individuals of European ancestry, and is rare in most global populations.
Genomic Location and Variant Characteristics
The variant rs17231520 is an inherited single nucleotide polymorphism situated on chromosome 6 within the ESR1 genomic region. At this position, human DNA sequences commonly present with either an adenine (A) or guanine (G) base. Because rs17231520 is an intronic or non-coding regulatory variant rather than an amino acid-altering missense mutation, it does not rewrite the primary structural sequence of the estrogen receptor protein. Instead, variants in these non-coding genomic segments typically influence local chromatin accessibility, transcription factor binding affinity, or splicing efficiency. According to central genetic repositories such as the National Center for Biotechnology Information dbSNP database, this polymorphism is categorized as a common germline variant. It represents natural, background human genetic variation rather than a rare high-impact pathogenic mutation.
The Biological Role of the ESR1 Gene
The ESR1 gene provides instructions for producing estrogen receptor alpha (ER-alpha), a nuclear hormone receptor and ligand-activated transcription factor. When estradiol or related estrogens bind to ER-alpha, the receptor translocates to the cell nucleus, where it binds directly to estrogen response elements in genomic DNA or cooperates with other transcriptional machinery. This signaling cascade regulates thousands of downstream genes essential for sexual differentiation, puberty, menstrual cycle dynamics, ovarian follicular development, endometrial maintenance, and bone density. In addition to female reproductive biology, estrogen signaling mediated by ESR1 plays an established regulatory role in human spermatogenesis and metabolic homeostasis. Because ESR1 acts as a master regulator of sex steroid response, inherited variations that subtly alter its expression levels or receptor sensitivity can influence baseline endocrine function across tissues.
Scientific Evidence and Clinical Significance
Research evaluated in genomic association studies and reproductive biology cohorts has classified rs17231520 as a trait-associated marker linked to variations in reproductive potential and reproductive endocrine function. The strength of the evidence supporting these phenotypic correlations is rated as moderate. In complex trait genetics, common variants in hormone receptor loci rarely produce large, isolated clinical effects on their own. Instead, they represent small statistical shifts in hormone sensitivity, circulating baseline marker levels, or ovarian response profiles observed across broad populations. Furthermore, because linkage disequilibrium within the ESR1 locus is extensive, observed associations may reflect the combined influence of tightly linked regulatory alleles across the region rather than rs17231520 acting as a solitary causal driver. It is not currently classified as a clinical diagnostic marker.
Population Frequency and Diversity
The alternate allele at rs17231520 occurs at varying frequencies depending on global ancestral background. In populations of European ancestry, cataloged genomic data note a minor allele frequency (MAF) of approximately 0.08, meaning roughly 8% of chromosomes in this group carry the variant allele. As a result, the vast majority of individuals of European descent carry the homozygous major genotype, while a smaller fraction are heterozygous carriers. Frequencies can vary across other continental populations, including East Asian, African, and admixed groups, reflecting ancient patterns of human demographic history and genetic drift. Comprehensive population resources like the Genome Aggregation Database (gnomAD) demonstrate that such allele frequency divergence is typical for non-coding regulatory variants located in large nuclear receptor genes.
Navigating Your Genetic Data
Discovering your rs17231520 genotype via consumer or research-grade genetic sequencing provides insight into inherited biological variation, but it cannot be used as a standalone diagnostic tool. Possessing a variant allele does not cause infertility, early menopause, or endocrine disorders, nor does having the common baseline genotype guarantee optimal reproductive outcomes. Complex reproductive traits are governed by the interplay of hundreds of polygenic loci, physiological status, lifestyle factors, and environmental exposures. Consequently, this variant should not be used to guide self-directed medical interventions, hormone therapies, or medication dosing. Anyone with questions regarding fertility, hormone levels, or reproductive planning should interpret their genetic results in consultation with a board-certified genetic counselor or licensed reproductive endocrinologist.
How common is this variant?
The minor allele at rs17231520 has an estimated frequency of approximately 0.08 (8%) in populations of European ancestry. Consequently, homozygous reference genotypes predominate in these groups, while homozygous variant genotypes remain relatively infrequent.
Frequently asked questions
Does having the rs17231520 variant mean I will experience fertility problems?
No. The rs17231520 variant is an inherited marker linked to small, statistical variations in endocrine traits across broad populations, not a causal diagnostic mutation for infertility. Reproductive capacity is determined by a wide array of environmental, anatomical, lifestyle, and polygenic factors.
Is rs17231520 used to prescribe or adjust hormone replacement therapy?
No, clinical pharmacogenomics guidelines such as those from CPIC or PharmGKB do not include rs17231520 for modifying hormone therapy or medication doses. Medical decisions regarding hormone use must always be guided by clinical evaluation, lab testing, and discussions with your healthcare provider.
How does ESR1 influence estrogen in the body?
The ESR1 gene encodes estrogen receptor alpha, a cellular receptor that binds circulating estrogen molecules. Once bound, this receptor acts as a transcription factor in the nucleus to turn on or regulate genes that govern menstrual cycles, cell growth, bone maintenance, and reproductive tissues.
Can lifestyle or diet change the effects of my rs17231520 genotype?
Your inherited DNA sequence cannot be changed, but lifestyle habits such as balanced nutrition, regular exercise, and avoiding tobacco directly support overall endocrine and reproductive health. Because rs17231520 has only modest statistical associations, healthy daily practices play a far larger role in hormonal well-being than a single genetic marker.
Sources & further reading
Educational information only, last refreshed 9/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17231520?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ESR1
This variant in the estrogen receptor 1 gene is associated with human reproductive behavior and influences estrogen-responsive gene expression.
This variant in the estrogen receptor 1 gene is associated with an increased risk of endometriosis and may influence cognitive aging.
Estrogen receptor 1 variant associated with altered circulating estradiol levels, follicular maturation, and variability in age at natural menopause.
Variant in estrogen receptor 1 associated with variation in female reproductive timing, including age at menarche and natural menopause onset.
Common polymorphism in estrogen receptor alpha (ESR1) affecting target tissue responsiveness to estrogen, recurrent pregnancy loss risk, and bone-reproductive axis interactions.
Estrogen receptor 1 regulatory variant associated with variation in timing of menarche and bone density response to sex hormones.